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Abstract
Introduction In adults with a suspicion of peripheral bone infection, evidence-based guidelines in choosing the most accurate
diagnostic strategy are lacking.
Aim and methods To provide an evidence-based, multidisciplinary consensus document on the diagnostic management of adult
patients with PBIs, we performed a systematic review of relevant infectious, microbiological, orthopedic, radiological, and
nuclear medicine literature. Delegates from four European societies (European Bone and Joint Infection Society, European
Society of Microbiology and Infectious Diseases, European Society or Radiology, and European Association of Nuclear
Medicine) defined clinical questions to be addressed, thoroughly reviewed the literature pertinent to each of the questions, and
thereby evaluated the diagnostic accuracy of each diagnostic technique. Inclusion of the papers per statement was based on a
PICO (Population/problem – Intervention/indicator – Comparator – Outcome) question following the strategy reported by the
Oxford Centre for Evidence-based Medicine. For each statement, the level of evidence was graded according to the 2011 review
of the Oxford Centre for Evidence-based Medicine. All approved statements were addressed taking into consideration the
available diagnostic procedures, patient acceptance, tolerability, complications, and costs in Europe. Finally, a commonly
agreed-upon diagnostic flowchart was developed.
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Abbreviations
PBI Peripheral bone infection
CRP C-reactive protein
ESR Erythrocyte sedimentation rate
WBC White blood cells
PICO Population/problem – Intervention/indicator –
Comparator – Outcome
CT Computerized tomography
EANM European Association of Nuclear Medicine
ESR European Society of Radiology
EBJIS European Bone and Joint Infection Society
ESCMID European Society of Clinical Microbiology and
Infectious Diseases
OCEBM Oxford Centre for Evidence-based Medicine
MRI Magnetic resonance imaging
FDG 18F-fluorodeoxyglucose
99mTc Technetium
PET Positron emission tomography
AGA Anti-granulocyte antibodies
mAbs Monoclonal antibodies
SPECT Single-photon emission computerized
tomography
US Ultrasound
HMPAO Hexamethylpropylene-amine oxime
T/B Target-to-background ratio
Oxine 8-hydroxyquinoline
MARS Metal artifact reduction sequences
MAVRIC Multiacquisition with variable-resonance image
combination
SEMAC Slice encoding for metal artifact correction
Preamble
The European Association of Nuclear Medicine (EANM) is a
professional nonprofit medical association that facilitates
communication worldwide between individuals pursuing clin-
ical and research excellence in nuclear medicine. The EANM
was founded in 1985. EANM members are physicians, tech-
nologists, and scientists specializing in the research and prac-
tice of nuclear medicine.
The EANM will periodically define new guidelines for
nuclear medicine practice to help advance the science of nu-
clear medicine and to improve the quality of service to patients
throughout the world. Existing practice guidelines will be
reviewed for revision or renewal, as appropriate, on their fifth
anniversary or sooner, if indicated.
Each practice guideline, representing a policy statement by
the EANM, has undergone a thorough consensus process in
which it has been subjected to extensive review. The EANM
recognizes that the safe and effective use of diagnostic nuclear
medicine imaging requires specific training, skills, and tech-
niques, as described in each document. Reproduction or mod-
ification of the published practice guideline by those entities
not providing these services is not authorized.
The present guideline was developed collaboratively by the
EANM with the European Society of Radiology (ESR), the
European Bone and Joint Infection Society (EBJIS), and the
European Society of Microbiology and Infectious Diseases
(ESCMID).
These guidelines are an educational tool designed to assist
practitioners in providing appropriate care for patients. They
are not inflexible rules or requirements of practice and are not
intended, nor should they be used, to establish a legal standard
of care. For these reasons and those set forth below, the in-
volved societies caution against the use of these guidelines in
litigation in which the clinical decisions of a practitioner are
called into question.
The ultimate judgment regarding the propriety of any spe-
cific procedure or course of action must be made by the phy-
sician or medical physicist in light of all the circumstances
presented. Thus, there is no implication that an approach dif-
fering from the guidelines, standing alone, is below the stan-
dard of care. To the contrary, a conscientious practitioner may
responsibly adopt a course of action different from that set
forth in the guidelines when, in the reasonable judgment of
the practitioner, such course of action is indicated by the con-
dition of the patient, limitations of available resources, or ad-
vances in knowledge or technology subsequent to publication
of the guidelines.
The practice of medicine includes both the art and the sci-
ence of the prevention, diagnosis, alleviation, and treatment of
disease. The variety and complexity of human conditions
make it impossible to always reach the most appropriate diag-
nosis or to predict with certainty a particular response to treat-
ment. Therefore, it should be recognized that adherence to
these guidelines will not ensure an accurate diagnosis or a
successful outcome. All that should be expected is that the
practitioner will follow a reasonable course of action based
on current knowledge, available resources, and the needs of
the patient to deliver effective and safe medical care. The sole
purpose of these guidelines is to assist practitioners in achiev-
ing this objective.
Introduction
Peripheral bone infections (PBI) include osteitis and osteomy-
elitis. Osteitis is an external bacterial infection of the bone and
surrounding soft tissues after trauma and/or surgery, and can
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be divided in acute (within the first 8 weeks) and chronic (>
8 weeks). Osteomyelitis refers to a primary infection of the
bone marrow (mostly endogenous by hematogenous spread)
with subsequent involvement of the cortical bone [1]. The
strategy to diagnose an infection of the bone is similar for
osteitis and for osteomyelitis. In the literature, osteitis and
osteomyelitis are used interchangeably, no clear distinction
is used between the two entities.
The most frequent origin of osteomyelitis is exogenous,
following trauma or surgery, but they also can develop by
contiguous spread from adjacent soft tissue or joint infection.
A hematogenous spread of microorganisms may also be the
origin of the infection [2]. In the elderly, a reactivation of a site
of quiescent hematogenous osteomyelitis acquired during
childhood can occur [3]. Identification of patients with a
foreign-body implant is important, both because of their high
susceptibility to infection and because of treatment challenges.
People with diabetes may suffer from osteomyelitis secondary
to vascular insufficiency following a foot soft tissue infection
that spreads to bone [2].
Osteomyelitis can be classified as acute or chronic. The
hallmark of acute osteomyelitis is the simultaneous presence
of pathogens and necrotic bone. Acute osteomyelitis, if not
promptly and efficaciously treated, becomes a chronic infec-
tion, which is characterized by the presence of a necrotic piece
of devascularized bone, called sequestrum. A periosteal reac-
tive process with new bone formation develops around the
necrotic area and may be associated with sinus tracking to
the skin surface [4]. Regarding the etiology, hematogenous
osteomyelitis is almost always a monomicrobial infection.
Staphylococcus aureus is the most frequent causative micro-
organism followed by coagulase-negative staphylococci, aer-
obic Gram-negative bacteria, and Peptostreptococcus spp. [5].
In contrast to hematogenous osteomyelitis, secondary osteo-
myelitis is more frequently polymicrobial. Staphylococcus
aureus and coagulase-negative staphylococci account for
most bacteria isolated in this type of osteomyelitis. However,
Gram-negative bacilli and anaerobic organisms are also fre-
quently isolated [3].
PBI behave differently from infections of the axial skele-
ton, especially spine, and therefore diagnostic possibilities
differ between infections in peripheral bone compared to axial
bone. The etiology, behavior, and diagnostic possibilities also
differ between children (e.g., more acute osteomyelitis) and
adults. This guideline focuses exclusively on PBI in adults.
Infections in the diabetic foot are excluded in this guideline,
since these infections behave differently due to vascular and
neuropathic impairment. Guidelines for the diagnosis of dia-
betic foot infection are being developed in another joint
European society project.
The incidence of peripheral bone infection in the developed
countries is less than 2% per year [6], but also higher inci-
dence rates (2–4%) have been reported after surgical care of
an open or closed fracture [7]. The incidence may even be up
to 19% when trauma surgery takes place in an acute setting
with possibly contaminated open fractures and concomitant
soft tissue injuries [8, 9]. The incidence further increases in
immunocompromised hosts, for example due to other diseases
(HIV, autoimmune diseases), treatment (chemotherapy, im-
munosuppressive therapy), drug or alcohol abuse, or infec-
tious root-canalled teeth [2].
In the acute phase after surgery, infection can usually easily
be recognized by clinical examination (fever, redness, swell-
ing, wound leakage, pain and disability of the affected body
part). In the later phases, there can be clear signs of disease
(fistula, purulent discharge), but often signs are subtler (slight-
ly elevated temperature of the skin, diffuse pain) or not present
at all and diagnosis may be very difficult at times. Peripheral
bone infections are a serious healthcare threat due to several
factors: the difficulty in making an early diagnosis (especially
in low grade, chronic infections), treatment duration is long-
lasting, often multiple surgical interventions are necessary,
recurrence rate is high, and the impact on daily life for the
affected patient is strong. Furthermore, when hematogenous
spread occurs, PBI can even be life–threatening. Therefore,
accurate diagnosis should be settled as early as possible, in
order to promptly start an appropriate treatment and to avoid
serious complications.
The diagnostic problem in PBI is that there is no single
routine test available that can detect an infection with suffi-
ciently high diagnostic accuracy. Mostly, a combination of
clinical, laboratory, microbiological, and imaging tests is per-
formed based on personal experience, available techniques,
and expertise in the institute and financial aspects.
Unfortunately, all available diagnostic tools have their
limitations.
Current recommendations for diagnosing peripheral bone
infection are scarce and all previous literature regarding the
subject has certain limitations and shortcomings, such as sole-
ly based on expert opinions and/or local consensus meetings
and not strictly focused on PBI. Moreover, they are affected
by several shortcomings: absence of multidisciplinary ap-
proach, failure to provide a comprehensive diagnostic flow-
chart, and/or lack of inclusion of up-to-date diagnostic tech-
nology. International evidence-based guidelines in choosing
the most accurate diagnostic strategy for PBI are lacking.
Qualified members of the European Association of Nuclear
Medicine (EANM), European Society of Radiology (ESR),
European Society of Bone and Joint Society (EBJIS), and
European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) had already developed a multidisciplin-
ary approach to design a diagnostic flowchart for the manage-
ment of PBIs [6].
An expert panel consisting of nuclear medicine physicians,
infectious diseases specialists, radiologists, and orthopedic
surgeons met on the occasion of the 20th congress of the
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EANM. The meeting led to the recognition amongst members
of EANM, EBJIS, ESR, and ESCMID that a practical
evidence-based guideline for diagnosing peripheral bone in-
fections was needed. A homogeneous management of PBIs
diagnosis trough a co-ordinated international, multi-
disciplinary guidance would improve the sensitivity of diag-
nosis and consequently lead to a better outcome of patients
with PBIs.
We therefore performed a systematic review of the articles
published on this topic, in order to provide this consensus
document on the diagnostic management of adult patients
with PBIs, with special emphasis on radiologic and nuclear-
medicine techniques. Our recommendations have been drawn
up so as to be useful for a wide range of health care profes-
sionals, especially for radiologists, nuclear medicine physi-
cians, infectious diseases specialists, and orthopedics.
Methods
Working group
After several joint symposia and the publication of the expert-
based guidelines, we recognized that a multidisciplinary
evidence-based guideline for diagnosing peripheral bone in-
fections was needed. This joint society project started in 2015
and a working group was created with delegates from four
European societies: the European Association of Nuclear
Medicine (EANM), the European Bone and Joint Infection
Society (EBJIS), the European Society of Microbiology and
Infectious Diseases (ESCMID), and the European Society of
Radiology (ESR). The delegates first met in Vienna
(November 2015) to define the statements and after that in
Rome (February 2016) to refine the statements and to define
the final statements, based on available evidence that was
circulated first among all participants. Finally, all delegates
approved the final version of each statement.
Statements, literature search, and scoring system
Uniform statements were addressed for each topic, with the
aim of positioning all diagnostic procedures in a commonly
agreed and evidence-based diagnostic flowchart. Literature
search for the statements is described in Appendix 1. All in-
cluded papers per statement were thoroughly read and ana-
lyzed and a BLevel of Evidence^ was provided in consensus
with all delegates for each paper according to the documents
for levels of evidence provided by OCEBM [10]. Each con-
sensus statement is followed by a level of evidence, defined by
the average of the levels of evidences of each included paper,
and a short comment derived from analysis of the relevant
literature. Statements are intended to be read in context with
qualifying comments and not read in isolation.
Available diagnostic methods for PBI
Clinical assessment, symptoms, and signs
of peripheral bone infection
In acute cases, individuals may report a generalized feeling of
illness, loss of appetite, fatigue, nausea, and fever. Pain is the
most common local symptom, and there may be a reduced
ability to use the affected body part. A history of recent trau-
ma, surgery, or infection of another organ (i.e., lungs, bladder)
can be present. Individuals with chronic osteomyelitis may
have a history of an acute episode. The patient may have an
underlying immune system disease or peripheral vascular dis-
ease. The patient must be questioned about intravenous drug
abuse and alcoholism. A complete medical history should be
obtained, including all current and prior illnesses and injuries
[2]. On physical examination, there can be clear signs of dis-
ease, like a direct fistula to the bone and purulent discharge,
but often signs are more subtle like slight erythema and swell-
ing or sub-febrile temperature and diffuse pain. Fever, signs of
dehydration or other signs of blood infection (sepsis) may be
evident. Range of motion of joints may be reduced [11]. In
analogy with ulcers in patients with a diabetic foot pointing to
osteomyelitis, ulcers in the tibia often reflect osteomyelitis.
Therefore a probe-to-bone test can be helpful in establishing
the diagnosis of PBI. In this test, the physician palpates the
bone with a metal probe. This simple bedside procedure is
based on the concept that if the probe can reach bone, so can
infectious bacteria [Lavery 2007].
Value of laboratory parameters
The specificity of elevated laboratory parameters of inflam-
mation (white blood cell count, erythrocyte sedimentation rate
(ESR), C-reactive protein (CRP), and procalcitonin) in differ-
entiating PBI from other clinical conditions is low. In adult
patients with PBI, ESR and CRP may be elevated, but on the
contrary white blood cell counts is often in the normal range.
Therefore, these parameters are not able to sufficiently dis-
criminate the presence or absence of infection. However, a
sharp increase of ESR and CRP may be helpful in confirming
the diagnosis of PBI in the clinical context of a high level of
suspicion [12] and may therefore influence the choice of im-
aging modality to be performed first. Also, serum
procalcitonin may be used as a diagnostic marker for PBI
[13]. Blood cultures should be performed for both aerobic
and anaerobic germs in febrile patients in addition to biopsy,
when possible.
Bone biopsy
The gold standard for the correct identification of the causa-
tive microorganism of PBI is represented by culture of
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infected bone. Prior to collecting microbiological samples,
any antibiotic regimen should be discontinued for 2 weeks,
provided the progression of the disease allows this.
Biopsies should be taken under image guidance to provide
representative samples. Bone is easily visualized with conven-
tional X-ray and fluoroscopy. However, bone biopsies are
generally conducted using CT guidance, which has the advan-
tage of providing higher contrast resolution and better
visualizaion of surrounding soft tissues, thus allowing for bet-
ter evaluation of the exact location of the lesion and position
of the needle. MRI guidance is rarely used for obtaining a
bone biopsy. Because of the electromagnetic radiation,
MRI-guided bone biopsy requires a special needle made
of non-ferromagnetic stainless steel. Other disadvantages
of MRI are longer procedural time and higher costs.
MRI guidance should only be used in very selected
cases like pediatric ones [14].
Bone biopsy samples should always be collected from a
zone in which the bone structure is visibly inflamed. Tissue
near visible bone or sequestra is informative. Collected pieces
should be divided into two pieces for bacteriology and
histology.
A minimum of three tissue samples should be collected.
The more samples that are withdrawn, the less chance of an
incorrect assessment due to contamination is reported.
Whenever bone biopsies are done, the samples should be sent
for aerobic and anaerobic cultures, cultures for mycobacteria
and fungi should be performed in patients with clinical and
epidemiological features supporting a suspicion for these eti-
ologies. Samples collected directly from the skin should be
avoided since these biopsies are often contaminated with skin
microbes, leading to false-positive results. Histopathological
analysis is essential for confirming or excluding the diagnosis
of infection. Visualization of granulatomatous lesions with
positive Ziehl–Neelsen staining may allow the diagnosis of
mycobacterial infection (e.g., Mycobacterium tuberculosis).
Because bone biopsy is an invasive diagnostic meth-
od, several studies examined the diagnostic values of
sinus tract cultures. However, these tract cultures are
often contaminated with skin microbes, leading to a
higher number of false-positive results. Superficial swab
cultures showed inferior diagnostic values to sinus tract
cultures and bone biopsy, and should not be used. New
molecular methods can further improve the microbiolog-
ical diagnosis [15].
Radiological and nuclear medicine imaging methods
and limitations
Several commonly used radiological and nuclear-medicine
imaging methods are available (see Tables 1 and 2). An ex-
tensive description on the correct use of these techniques is
provided in Appendix 2 [16–24]. The concerns on the use of
ionizing radiation is described in Appendix 3 (https://ec.
europa.eu/energy/sites/ener/files/documents/CELEX-
32013L0059-EN-TXT.pdf, [25]).
Consensus statements
All performed PICOs for the statements and the papers
finally included for the level of evidence are mentioned
in Appendix 4.
1. Patients presenting with clinical and radiological signs
of peripheral bone infection or a positive probe-to-
bone test may require further diagnostic procedures.
Level of evidence: 5
In case of clinical and radiological suspicion of peripheral
bone infection, further diagnostic testing can be indicated to
reveal severity and extent of the infection. Patients with acute
peripheral bone infection can present with local pain, swell-
ing, erythema, and warmth at the site of infection, and system-
ic symptoms such as fever and general illness. If a fistula is
present, a probe to the bone test can be performed. In diabetic
foot, this is indicative of bone infection, however, there is no
literature supporting that statement in PBI. In general, in the
acute phase with clear clinical signs, advanced imaging is
often not necessary.
2. Fistula direct to the bone and purulent discharge are
evidence of bone infection.
Level of evidence: 5
There are no articles that provide evidence for this state-
ment. It is based on common medical reasoning; bacteria that
normally are present as part of skin flora superficially spread
and colonize the exposed bone thereby causing local
infection.
3. CRP, ESR, and WBC counts should always be per-
formed in patients suspected of having peripheral
bone infection for diagnostic purposes.
Level of evidence: 4
In patients with PBI, raised ESR and CRP can be present,
even if inconsistently, and can orientate versus a diagnosis of
infection. White blood cell counts are more rarely increased.
In patients with contiguous pedal osteomyelitis, the positive
predictive value of ESR in diagnosing osteomyelitis in pa-
tients without diabetes was 78%, and in those with diabetes
was 81%, with a negative predictive value 58 and 31%,
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respectively [26]. The concentration of CRP might be more
reliable for follow-up of the response to treatment [2]. The role
of serum procalcitonin was also evaluated in patients with
acute PBI and a cut-off of 0.4 ng/ml was found to be a sensi-
tive and specific marker in the diagnosis of acute osteomyelitis
[13].
4. Blood cultures should be considered in patients with
fever suspected of having peripheral bone infection for
diagnosing the involved bacteria
Level of evidence: 4
Blood cultures are positive mostly in hematogenous osteo-
myelitis. The evidence supporting the role of blood cultures in
diagnosing PBIs other than vertebral osteomyelitis in adult
patients is scanty. In our systematic review of the literature,
we found only one study that analyzed the role of bacteremia
in patients with bone infection. Adult patients with bone in-
fection, regardless of the mechanism involved (i.e., trauma,
bone surgery, joint replacement, bone damage resulting from
vascular and/or cutaneous lesions) were included if blood cul-
tures results were available. The authors found that bacteremia
occurred in nearly 20% of the patients presenting with bone
infection [27]. In this study, also patients with vertebral oste-
omyelitis were included and those were more frequently af-
fected by bacteremia (53% patients had positive blood cul-
ture). Patients with bone infection associated with skin and
soft tissue infections had positive blood cultures in 19% of
cases; patients with osteosynthesis and open or closed fracture
had positive blood cultures in 7% of cases. Importantly, only
41% of patients with bacteremia presented fever; this might
suggest that blood cultures should be performed in patients
with PBI irrespective of the presence of fever.
5. Conventional radiography is the first imaging modal-
ity to be performed in patients suspected of having
peripheral bone infection for diagnosis and follow-up.
Level of evidence: 3
Conventional radiography should always be performed first,
as it may suggest correct diagnosis, exclude other pathologic
conditions, and be correlated with other modalities. It is cheap
and widely available. Bone changes are seen usually after 7–
10 days from symptom onset, when 30–50% bone mass has
been lost. Soft tissue swelling can be the only finding at first.
Then, bone resorption and osteolysis can be seen. Last, perios-
teal reaction and bone formation can be detected. Sensitivity
and specificity of conventional radiography in detection of
acute osteomyelitis ranges between 43 and 75% and 75–83%,
respectively [16, 17]. In anatomically complex locations (e.g.,
shoulder, pelvis) CT may replace conventional radiographs.
6. In case of clinical and radiological signs of peripheral
bone infection, bone biopsy is the reference standard
for confirming infection and identifying the causative
microorganism.
Level of evidence: 4
Patients presenting with clinical and radiological signs of
peripheral bone infection may undergo bone biopsy to detect
infection and identify the causative microorganism. Evidence
is, however, conflicting and of low level.
Bernard et al. reported that surgical bone biopsy through
the sinus tract had a sensitivity of 87%, a specificity of 79%,
and a diagnostic accuracy of 82.5%, compared to those of
surgical bone biopsy through a clinically uninfected area
[28]. In a study analyzing 44 biopsy procedures performed
in patients with osteomyelitis underlying an open wound,
the large majority of biopsy cultures grew a bacterial isolate
[29]. In a further prospective study including 100 patients with
chronic osteomyelitis, bone cultures allowed etiologic diagno-
sis in 94% of cases; in the remaining cases, a diagnosis of OM
was performed by histopathology analysis [30]. The role of
culture of bone specimens obtained through a surgical biopsy
has been confirmed also by other studies [31–33]. On the
contrary, Wu et al. found a low rate of positivity for cultures
obtained by imaging-guided biopsy in patients with OM [34].
Different modalities are available for obtaining a bone
specimen, such as open bone biopsy, fine needle aspiration
(FNA), and needle puncture. Bone biopsy is usually per-
formed during the surgical debridement procedure.
However, it can worsen peripheral vascular disease and neu-
ropathy. Advantages of FNA over bone biopsy are that this
procedure is less disruptive to bone and allows multiple sam-
ples to be taken [35]. In case of an ulcer, needle puncture is
performed through normal skin surrounding the ulcer. This
procedure is minimally invasive, easily performed, and has a
greatly reduced risk of contamination [36]. With all of these
modalities, care must be taken to prevent the infection from
spreading to uninfected bone.
7. In case of clinical and radiological signs of peripheral
bone infection, sinus tract cultures and/or superficial
swab cultures should be discouraged in the diagnostic
work-up; bone biopsy is the gold standard.
Level of evidence: 4
Because bone biopsy is an invasive diagnostic tool, several
studies aimed to examine the diagnostic value of sinus tract
cultures and deep tissue cultures.
In our systematic review, we found five studies reporting
that sinus tract cultures are inappropriate to identify the bone
pathogen in osteomyelitis (https://ec.europa.eu/energy/sites/
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ener/files/documents/CELEX-32013L0059-EN-TXT.pdf,
[2–32, 37]). In a study retrospectively analyzing 50 patients
with chronic osteomyelitis, the concordance between bone
and non-bone specimens was 28%. Moreover, cultures from
non-bone specimens were false-negative in 52% of cases and
false-positive in 36% [31]. In a further prospective study includ-
ing patients with chronic osteomyelitis, the overall sensitivity
(50.9%), specificity (20%), predictive value (47.5%), and con-
cordance of sinus tract specimens with intraoperative bone
specimens (41.4%) were very low [32]. Khatri et al. reported
a poor correlation between wound and bone isolates [29]. In a
prospective study, 100 adult patients with chronic osteomyelitis
(excluding those with diabetic foot and decubitus ulcers) were
included, at least one non-bone and one bone specimen were
taken from each patient for microbiological analysis. Bone cul-
tures grew a microorganism in 94% of cases. Importantly, the
authors found that cultures of non-bone and bone specimens
were microbiologically concordant in only 30% of patients.
Slightly better concordance was found in chronic osteomyelitis
caused by Staphylococcus aureus (42%) [30].
Only a single study reported different findings. In a large
prospective non-randomized trial, in 140 patients with a cuta-
neous sinus tract, four microbiological samples were taken: two
consecutive sinus tract cultures with bone contact (at different
times), one surgical bone biopsy through the sinus tract, and
one surgical bone biopsy through an uninfected area outside the
sinus tract. The highest diagnostic accuracy rates in case of
monomicrobial osteomyelitis with sinus tract were found with
two concordant tract cultures with bone contact (94%). For
polymicrobial infections, the accuracy was somewhat lower
(79%). Even if this study supported reliability of two consecu-
tive sinus tract cultures, the authors concluded that consecutive
deep sinus tract specimens should not replace bone cultures in
situations where a biopsy can readily be obtained. Bone culture
remains the reference standard for the microbiological diagno-
sis of osteomyelitis; consecutive deep sinus tract cultures may
be used when a biopsy cannot be performed [28].
8. Antibiotic therapy should be discontinued before
biopsy
Level of evidence: 5
In clinical practice, the dogma that antibiotics should be
withheld before obtaining of microbiological cultures is well
recognized and is based on the assumption that antibiotic ex-
posure decreases the probability of bacterial identification
from cultures. Obtaining an etiological diagnosis of PBI is
extremely important for choosing the appropriate antimicrobi-
al treatment. The antibiotic treatment should be guided by
microbiological findings not only in order to improve the out-
come of patients with PBI but also for limiting the use of
unnecessary antibiotics and consequently limit the adverse
effects and the ecological impact of antibiotics. As a conse-
quence, all efforts should be made in order to obtain a micro-
biological diagnosis. No studies specifically assessing the im-
pact of antibiotic exposure on the rate of positivity of bacterial
cultures from bone biopsies in patients with PBIs have been
published. In our systematic review, we found only three stud-
ies that reported some data on the impact of antibiotic expo-
sure. Wu et al. found no significant differences in the culture
positivity rate with regard to antibiotic therapy before image-
guided biopsy [34]. Similarly, no significantly different diag-
nostic accuracy of microbiological cultures was found by
Bernard et al. in patients with concomitant antibiotic treatment
as compared with those without concomitant antibiotics [28].
In another study, no significant effect of prior antibiotic ther-
apy on rate of positivity of bacterial cultures was found [29].
However, all of these studies were not designed with the pur-
pose of investigating the issue of prior antimicrobial therapy,
were cohort studies, and included a small number of patients.
Even if published studies were not able to demonstrate an
effect of previous antibiotic therapy on the rate of microbio-
logical culture positivity, considering the limitation of studies
and the rationale for such recommendation, we recommend
that discontinuing or postponing antibiotics when feasible is
reasonable. Antimicrobial therapy should not be withheld in
patients with impending sepsis or hemodynamic instability.
The optimal duration of antibiotic-free time before bone biop-
sy has not been established.
9. CT should be used as an adjunct to conventional ra-
diographs in complex anatomic areas and is useful to
detect bone sequestra.
Level of evidence: 4
CT has the highest image resolution in the evaluation of
peripheral bone. Thus, it is indicated in the evaluation of com-
plex anatomic area, such as the shoulder and the pelvis. It can
be used to detect small foci of gas, and areas of cortical erosion
and destruction. CT is the modality of choice in areas of com-
plex anatomy for the detection of bone sequestra, mainly oc-
curring at later stages of osteomyelitis [18].
10. Non-contrast MRI has high diagnostic performance
in detecting peripheral bone infection.
Level of evidence: 2
MRI has several advantages in the evaluation of peripheral
bone infection. Not only it is able to evaluate infection of the
bony component with high diagnostic performance, but it can
also detect the presence and evaluate the extent of associated
soft tissues abnormalities, such as muscular involvement or
abscess formation. Non-contrast MRI has a sensitivity
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between 88 and 98%, a specificity between 70 and 96%, and a
diagnostic accuracy of 81–86% in the diagnosis of peripheral
osteomyelitis [19–21]. Apart from detecting bone infection,
MRI can also optimally differentiate other conditions which
clinically mimic infection including primary benign and ma-
lignant bone tumors, with the exception of cortical bone le-
sions (e.g., osteoid osteoma).
11. Intravenous administration of gadolinium-based
contrast agents does not increase the diagnostic per-
formance of MRI in peripheral bone infection
Level of evidence: 2
Intravenous gadolinium-based contrast administration may
help to better define the presence and extent of soft tissue
abscesses in acute peripheral bone infection but it does not
improve diagnostic performance [38]. It may also help avoid
overstaging by better differentiating osteomyelitis from sur-
rounding edema.
12. The presence of a metallic implant/fixation device is
not a contraindication to perform MRI in patients
with suspected peripheral bone infection.
Level of evidence: 5
The presence of a metallic implant or metallic fixation de-
vice does not represent a contraindication to MRI.
Traditionally, metallic implants were considered as potentially
limiting the outcome of a MRI examination due to the high
amount of susceptibility artifacts that could be generated by
the metal itself. More recently, the advent of implants made
with less ferromagnetic alloys and technical advancements of
MR sequences (metal artifact reduction sequences [MARS],
slice encoding for metal artifact correction [SEMAC], and
multi-acquisition with variable-resonance image combination
[MAVRIC]) made MRI fully feasible in patients with joint
implants, with artifacts mostly limited to the area of the im-
plant itself. However, some limitations to prosthesis geometry
persist, affecting the assessment of the joint–prosthesis inter-
face, and no papers are available on the topic; but this state-
ment is made based on evidence published for joint prosthesis,
a field with comparable issues.
13. Three-phase bone scintigraphy is a sensitive tech-
nique in patients suspected for peripheral bone infec-
tion although not highly specific.
Level of evidence: 2
All included papers (meta-analyses and systematic
reviews) for this statement report a similar high sensitivity,
but low specificity [39–43]. The difference between sensitiv-
ity and specificity can be explained by the non-specific signs
of peripheral bone infection on bone scintigraphy being in-
creased vascularity during the first two phases and increased
bone uptake at the late images. These three phases can also be
positive because of other reasons, such as post-traumatic
changes, fracture healing, recent surgery, etc. This explains
the lower specificity especially in the post-traumatic or post-
surgery setting. When using the three-phase bone scan,
SPECT/CT is advised in the late phase for exact localization
of the osteoblastic activity.
14. White blood cell (WBC) scintigraphy and
antigranulocyte antibody (AGA) scintigraphy have
similar high diagnostic accuracy for diagnosis of pe-
ripheral bone infection.
Level of evidence: 2
Out of the 54 papers retrieved from the PICO for this state-
ment, 14 were eventually included, only being clinical con-
trolled studies and systematic reviews. These papers report a
similar diagnostic accuracy for both WBC and AGA scintig-
raphy [42, 44–56]. However, the acquisition and interpretation
criteria adopted are not always the same, making the compar-
ison difficult between the used radiopharmaceuticals. The
whole IgG (besilesomab) has a different biodistribution
in vivo than the Fab fragment (sulesomab) and much more
similar to radiolabeled white blood cells [57]. In addition, it is
important to mention that two reports raise some questions
about the specificity of binding of anti-granulocyte Fab frag-
ment (sulesomab, Leukoscan®) to tissue infiltrating
granulocytes [54, 58]. These two reports do not, however,
bring sufficient scientific evidence for this assumption and
should therefore be considered as Bexpert opinions^ and not
entirely pertinent to this statement. Therefore, considering on-
ly papers dealing with diagnostic accuracy in peripheral bone
infections, the level of evidence for this statement is 2.
15. Pre-test probability of infection should be considered
for choosing between three-phase bone scan and
WBC scintigraphy (fractures, recent surgery,
osteosynthesis, highly positive serological tests).
Level of evidence: 5
Despite an extensive literature search, no original papers or
review articles could be retrieved that describe the importance
of the pre-test probability for a peripheral bone infection to
choose between three-phase bone scintigraphy or white blood
cell scintigraphy. However, based on daily clinical practice,
one always considers the pre-test probability before consider-
ing a particular imaging modality. Because three-phase bone
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scan has a high sensitivity, but low specificity especially in
‘violated’ bones, we recommend performing WBC scintigra-
phy in patients with suspicion of infection after recent surgery
or in the setting of metallic hardware in situ, or recent frac-
tures. In contrast, in patients with low likelihood for infection
based on clinical and biochemical parameters and non-
violated bone, a three-phase bone scan can be recommended
to exclude an infection because of high sensitivity, low cost,
and wide availability. The level of evidence for this statement
is 5, and should be regarded as an expert opinion.
16. a.18F-FDG-PET has high diagnostic accuracy in pe-
ripheral bone infection without fracture and
osteosynthesis.
Level of evidence: 2
b. WBC scintigraphy is the preferred nuclear-
medicine imaging technique of choice in patients
suspected of peripheral bone infection with recent
fracture of hardware in situ.
Level of evidence: 2
All included papers (both original and reviews) agree that
FDG-PET is a promising and accurate imaging technique for
peripheral bone infection without hardware in situ [6, 39, 51,
53, 59–64] but they also agree that there is not sufficient ev-
idence for using this modality as the current reference stan-
dard. Most studies are performed in patients with chronic os-
teomyelitis, so the role of FDG-PET in the acute phase is still
unknown. This number of cases is still too small to conclude
that FDG-PET is superior to WBC scintigraphy in PBI [63].
At the moment, both techniques (FDG-PET and WBC
scintigraphy) can be used with the same diagnostic accuracy
in patients with peripheral bone infection without recent frac-
ture and/or without metallic hardware in situ.
In patients with hardware in situ or with a recent fracture,
the number of patients imaged with FDG-PET is even more
limited. Only three studies exist that included > 10 patients
with metallic hardware in situ [64–66]. The retrospective
study of Wenter et al. included the largest number of patients
with hardware in situ [60], leading to a diagnostic accuracy of
Table 1 Pros and cons of advanced radiological techniques
Ultrasound CT MRI
Pros Useful for soft tissue extension and for biopsies
Widely available
Low cost
No radiation burden
Useful in performing image-guided biopsies
Widely available
Medium cost
High diagnostic performance
Feasible also with metallic implants in situ
No need for contrast agent
No radiation burden
Widely available
Medium cost
Cons Cannot be used to diagnose bone infection Possible artifacts due to metallic implants
Lower diagnostic accuracy than MRI
Radiation burden
Some false positivity due to edema
This table shows the pros and cons of radiological examinations to be performed as advanced diagnostic tests. From the data in literature, it emerges that
MRI has higher accuracy than CT and should be preferred when available
Table 2 Pros and cons of advanced nuclear-medicine techniques
Bone scan Antigranulocyte scan White blood cell scan FDG-PET/CT
Pros High sensitivity
Useful as screening
method in patients
with low probability
of an infection
Widely available
Low cost
High sensitivity and specificity
(but lower than WBC scan)
Widely available
Medium cost
SPECT/CT improves accuracy
High sensitivity and specificity, also
with metallic implants in situ
Not widely available
Medium costs
SPECT/CT improves accuracy
High sensitivity
High specificity in patients
without metallic implants
and without recent surgery
or fracture
Cons Low specificity
Moderate radiation burden
May induce Human anti-mouse
antibody (HAMA)
Moderate radiation exposure
Late imaging time point necessary
Moderate radiation exposure
Late imaging time point necessary
Blood manipulation
Needs approved laboratory and
trained personnel
Difficult to differentiate between
infection and inflammation
with metallic implants are in
situ, with recent surgery, or
recent fracture
Radiation exposure
High cost
This table shows the pros and cons of nuclear-medicine examinations to be performed as advanced diagnostic tests
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86%. Much more data is available for WBC scintigraphy in
patients with recent fractures or metallic hardware in situ and
this technique is still the preferred nuclear-imaging technique
in patients suspected of peripheral bone infection with recent
fracture or hardware in situ.
17. Hybrid SPECT-CTWBC imaging can be performed
for exact localization of infection site.
Level of evidence: 2
Since the development of hybrid imaging techniques such
as SPECT-CT, in general diagnostic accuracy has significantly
been increased due to the synergistic effect of combining path-
ophysiology with anatomy. However, in the recommendations
about acquisition and interpretation of WBC scintigraphy, on-
ly planar images on several time points are considered.
Theoretically, adding the SPECT-CT in positive cases would
also for this indication lead to a higher diagnostic accuracy.
Even though limited data is available (only eight included
papers, of which four were review articles), the advantage of
SPECT/CT over planar images is clear in all papers [23,
67–73]. This is well known for other indications; the better
resolution of SPECTand the added CTcomponent for anatomy
leads to higher diagnostic accuracy. All included papers agree
in their opinion: in patients with suspected peripheral bone
infection, SPECT/CT should be performed when there is posi-
tivity on the planar WBC images. Adding SPECT/CT leads to
better differentiation between bone involvement of the infection
and soft tissue infection and leads to better characterization of
Fig. 1 The suggested initial
diagnostic steps to undertake in
the suspicion of PBI, based on
published evidence. Of course not
all steps are required, this may
change in the individual patient.
Some steps can of course be
repeated when necessary.
Serological tests can be
performed over time since the
trend to increase or decrease is
more important than a single
value. At this moment, there is not
enough clinical evidence to
support the use of one advanced
diagnostic imaging technique
above the other. There is a lack of
studies with large patient numbers
and there are hardly no
comparative studies. Therefore,
the choice of which advanced
diagnostic modality to be used
first depends on several factors,
such as experience of the imaging
specialist, costs, availability,
radiation burden and local
expertise (see also Tables 1 and
2). In many hospitals, MRI is
considered as the first advanced
imaging modality in daily
practice, mainly because there is
no radiation involved. In patients
with metallic hardware, however,
there is sufficient literature to
support a preferential use of white
blood cell scintigraphy
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the extent of the infection. The CTcomponent itself can help in
anatomical difficult cases, e.g., after a major trauma.
18. When having a suspicion for hematogenous spread of
the infection, 18F-FDG-PET/CT is the first imaging
modality of choice.
Level of evidence: 5
Although an extensive PICO was performed with trying
many search terms, hardly any articles were found that de-
scribe the role of FDG-PETwhen having suspicion of dissem-
ination in patients with a peripheral bone infection. Only an
overview paper about pitfalls in infection imaging was re-
trieved (expert opinion) [74]. However, from daily clinical
practice, the benefits of an easy whole-body imaging tech-
nique to visualize all infectious lesions within a patient are
clear. The technique is highly sensitive, although not very
specific, easy to perform, and comfortable for the patient.
So, although evidence is low, we recommend the use of
FDG-PET/CT when having suspicion of hematogenous
spread of infection.
Evidence-based diagnostic flowchart
Based on the above-mentioned statements and evidence from
published literature, we have developed the diagnostic flow-
chart shown in Figs. 1 and 2.
In some cases, the flow was integrated by consensus opin-
ion amongst the experts, since not all steps are always clearly
deducible from literature or from level 1–2 articles. The flow-
chart does not take into consideration socio-economical fac-
tors and the availability of diagnostic methods. It also pre-
sumes that all exams are performed at their best (possibly
following procedural guidelines published by each society,
when available) and by expert professionals.
The flowchart starts with the suggested initial steps to un-
dertake when having a suspicion for PBI, based on the afore-
mentioned evidence. Clinical examination, laboratory tests,
and conventional X-ray should be performed in all cases.
Laboratory tests should be performed over time since the trend
to increase or decrease is more important than a single value.
The probe-to-bone test can be helpful in some cases to estab-
lish the diagnosis PBI, e.g., when ulcers in the tibia are
present.
Fig. 2 The suggested path to
undertake when nuclear-medicine
techniques are considered in the
suspicion of PBI, based on
published evidence and expert
opinion. This flowchart indicates
when to use which nuclear
imaging modality and is based on
scientific evidence as mentioned
in the statements
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When still having a suspicion at this stage, image-guided
bone biopsy should be performed to detect infection and iden-
tify the causative micro-organism. Sinus tract cultures can
cause false-positive results due to contamination, and superfi-
cial swab cultures have a lower diagnostic than bone biopsy.
Besides the bone biopsy, advanced diagnostic imaging tests
should be performed. Since there are not enough well-
designed studies (with a level of evidence 1) available that
directly compare radiological with nuclear-medicine tech-
niques, we decided to split the imaging techniques into radio-
logical and nuclear-medicine techniques. When choosing an
advanced diagnostic imaging test, a further stratification
should be performed based on the pre-test probability of infec-
tion. Based on local experience, one can decide to start with
radiological techniques (MRI has the best diagnostic accuracy)
and use nuclear-medicine techniques in case of equivocal MRI
results. If a center is very experienced in nuclear-medicine
modalities, one can decide to start with these techniques.
Which nuclear-medicinemodality should be used first depends
on the following: is there a low or a high probability of infec-
tion? Was there recent surgery? Was there a recent fracture? Is
there metallic hardware in situ? For the answers to these ques-
tions, see the nuclear part of the flowchart and tables.
Conclusions and final recommendations
This is the first proposal of a diagnostic flowchart in patients
with suspicion of a peripheral bone infection based on evi-
dence available from literature. However, since no large mul-
ticenter prospective comparative studies exist, we should con-
clude that the available evidence is mostly limited. Therefore,
we also had to include expert opinion (by consensus) in the
presented flowchart.We think that the presented flowchart can
be a first step in many centers and can form a basis to start
large prospective studies to directly compare the different ad-
vanced imaging techniques to develop future flowcharts.
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